)
)
)
Eleva GmbH
Eleva is a clinical-stage biopharmaceutical company that strives to bring novel therapies to patients with serious unmet medical needs. Our unique moss-based platform opens new possibilities for expressing biologics with complex structural and functional profiles—molecules that often remain out of reach for conventional systems. This differentiating capability positions Eleva to advance first- and best-in-class therapeutics across multiple areas of high medical need.
We are currently advancing two proprietary clinical programs, which have the potential to change the life of patients affected from complement-related disorders (e.g. C3 Glomerulopathy, IgA Nephropathy and dry AMD) and Fabry disease.
As partnerships are at the core of our strategy, Eleva is currently looking for additional investors and partners to accelerate the development of these clinical assets towards market approval.
Address
FreiburgGermany
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)